Case number 1:22-cv-00114
Otsuka Pharmaceutical Co., Ltd. et al v. Mylan Laboratories Limited et al > Summary
Court Case Number 1:22-cv-00114
Filing Date Nov 10, 2022
Termination Date Mar 7, 2023
Court West Virginia Northern District Court
Status Dismissed - Other
JudgesThomas S. Kleeh
Defendant
Plaintiff Attorneys
H. Lundbeck A/S
Attorney Name: Daniel R. Higginbotham
Thomas Combs & Spann
Defendant Attorneys
Viatris Inc.
Attorney Name: Brandon M. White
Perkins Coie
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 11400087 | Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function | Aug 2, 2022 |
| 11344547 | Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function | May 31, 2022 |
| 11154553 | Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function | Oct 26, 2021 |
| 10980803 | Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function | Apr 20, 2021 |
| 10525057 | Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function | Jan 7, 2020 |
| 08722679 | Controlled release sterile injectable aripiprazole formulation and method | May 13, 2014 |
| 08399469 | Low hygroscopic aripiprazole drug substance and processes for the preparation thereof | Mar 19, 2013 |
| 08338427 | Methods for administering aripiprazole | Dec 25, 2012 |
| 08030313 | Controlled release sterile injectable aripiprazole formulation and method | Oct 4, 2011 |
